关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nicpbp.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  4 2 9 8 4 9 3 位浏览者
您当前的位置:首页 >> 正文

基于微流控芯片技术的中药小蓟诱导肺癌A549细胞凋亡用药部位精准分析

Precise analysis of the apoptosis effect of medicinal parts of Cirsium setosum to lung cancer A549 cell based on microfluidic chip

作者(英文):
分类号:R917
出版年·卷·期(页码):2019,39 (3):393-397
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的:通过对小蓟药材的不同用药部位进行诱导肿瘤细胞凋亡的精准分析,明确小蓟药材不同药用部位的合理使用。方法:应用微流控芯片平台得到不同用药部位的体外抗癌药效结果,HPLC色谱法建立不同用药部位的指纹图谱,灰色关联度软件计算出不同用药部位指纹图谱中各个峰面积与其凋亡坏死率的关联度,对其关联度较大的成分进行快速鉴定与分析。结果:小蓟药材的不同用药部位的体外药效具有一定的差异性,其中诱导肺癌细胞凋亡坏死能力花 > 叶 > 茎 ≈ 根;其中橙皮苷、咖啡酸、蒙花苷与抗肿瘤药效关联度排名前三。结论:本实验明确了小蓟不同用药部位抗肺癌的药效物质基础。基于体外药效,小蓟花有进行深入研究的潜力。为小蓟药材的质量控制以及不同用药部位的合理使用提供了一个科学的依据及分析方法。

-----英文摘要:---------------------------------------------------------------------------------------

Objective: To make clear for the rational use of medicinal parts of Cirsium setosum by conducting precise analysis of the apoptosis effect of medicinal parts of Cirsium setosum to lung cancer A549 cell. Methods: Using the microfluidic chip platform to get the inhibition ratio information about different parts of Cirsium setosum extractive to lung cancer A549 cell. Identify the chemical compounds by comparison the retention time of different standard reference substances by the HPLC and the fingerprint of different parts of Cirsium setosum was set up. Finally,calculate the correlation coefficient of common peaks area to pesticide effects of Cirsium setosum extractive by the GreyModeling software. Results: Different parts of Cirsium setosum has different inhibition effect to A549 cells. The GreyModeling software shows that hesperidin, linarin, caffeic acid in Cirsium setosum has the higher correlation coefficient than other compounds in anticancer activity. Conclusion: The flower part of Cirsium setosum has the best pesticide effect to A549 cells. Hesperidin, linarin and caffeic acid could be the main anticancer activity medicinal effective ingredients in Cirsium setosum.

-----参考文献:---------------------------------------------------------------------------------------

[1] 柯睿,朱恩圆,侴桂新. 小蓟中一个新的苯丙素苷类化合物[J]. 药学学报,2010, 45(7):879 KE R,ZHU EY,CHOU GX. A new phenylpropanoid glycoside from Cirsium setosum[J]. Acta Pharm Sin,2010, 45(7):879
[2] 孟永海,王秋红,姜海,等. 小蓟化学成分研究[J]. 中药材, 2009, 32(1):58 MENG YH, WANG QH, JIANG H, et al. Study on Chemical Constituents of Herba Cirsii[J]. J Chin Med Mater,2009,32(1):58
[3] SUN Q,CHANG L,REN Y,et al. Simultaneous analysis of 11 main active components in Cirsium setosum based on HPLC-ESI-MS/MS and combined with statistical methods[J]. J Sep Sci,2012;35:2897
[4] 李璐,罗建光,孔令义. 小蓟炒炭前后蒙花苷的含量测定[J]. 中国现代中药,2010, 12(5):23 LI L,LUO JG,KONG LY,et al. Determination of linarinin in Herba Cirsii and its carbonized product[J]. Mod Chin Med,2010,12(5):23
[5] 李煜,王振飞,贾瑞贞. 小蓟水提液对4种癌细胞生长抑制作用的研究[J]. 中华中医药学刊, 2008(2):274 LI Y, WANG ZF, JIA RZ. Study on inhibitory effects of extract of Cirsium setosum(Willd.)MB on growth of four kinds of human Carcinoma cells[J]. Chin Arch Tradit Chin Med,2008(2):274
[6] 樊佳新,王帅,孟宪生,等. 基于微流控芯片技术的荆芥诱导肺肿瘤细胞凋亡谱效关系研究[J]. 药学学报, 2017, 52(1):126 FAN JX,WANG S,MENG XS,et al. Study of cancer cell apoptosis induced by Schizonepeta tenuifolia with microfluidic chip technology[J]. Acta Pharm Sin,2017, 52(1):126
[7] CHEN YH,HAO LJ,HUNG CP,et al. Apoptotic effect of cisplatin and cordycepin on OC3 human oral cancer cells[J]. Chin J Integr Med, 2014, 20(8):624
[8] 马立东,王乙同,孟宪生,等. 基于微流控芯片的细胞迁移模型及其在黄芩苷药效学研究上的应用[J]. 中国药科大学学报, 2014, 45(3):352. MA LD,WANG YT,MENG XS,et al. A cell migration model based on microfluidics and its application for baicalin pharmacodynamics research[J]. J China Pharm Univ,2014, 45(3):352
[9] 顾玉诚,屠呦呦. 小蓟化学成分研究[J]. 中国中药杂志,1992, 17(9):547 GU YC,TU YY. Studies on chemical constituents of Cirsium Segetum (Bge.)Kitam[J]. China J Chin Mater Med,1992,17(9):547
[10] 许浚,张铁军,龚苏晓,等. 小蓟止血活性部位的化学成分研究[J]. 中草药,2010, 41(4):542 XU J, ZHANG TJ, GONG SX, et al. Studies on the chemical constituents of hemostatic active parts of artichoke[J]. Chin Tradit Herb Drugs,2010, 41(4):542
[11] 冯子明,杨桠楠,姜建双,等. 小蓟的化学成分研究[J]. 中国实验方剂学杂志,2012, 18(6):87 FENG ZH,YANG YN,JIANG JS,et al. Chemical constituents from Cirsium setosum[J]. Chin J Exp Tradit Med Form,2012,18(6):87
[12] LIN L,LIN XX,LIN LY,et al. Integrated microfluidic platform with multiple functions to probe the tumor-endothelial cell interaction[J]. Anal Chem,2017, 89(18):10037
[13] LI N, ZHANG WF,KHAN M,et al. MoS2-LA-PEI nanocomposite carrier for real-time imaging of ATP metabolism in glioma stem cells co-cultured with endothelial cells on a microfluidic system[J]. Biosens Bioelectr, 2018, 99:142
[14] 王鹤辰,樊佳新,包永睿,等. 基于灰色关联法研究胆矾中元素对A549细胞的体外抑制作用[J]. 中国现代应用药学,2017, 34(11):1522 WANG HC, FAN JX, BAO YR, et al. Study on the inhibition lung cancer cell A549 with traditional Chinese mineral drugs Danfan in vitro basing on the grey correlation method[J]. Chin J Mod Appl Pharm,2017, 34(11):1522
[15] 张铁军,王杰,陈常青,等. 基于中药属性和作用特点的中药质量标志物研究与质量评价路径[J]. 中草药, 2017, 48(6):1051 ZHANG TJ, WANG J, CHEN CQ, et al. Method of quality marker research and quality evaluation of Chinese materia medica based on drug properties and effect characteristics[J]. Chin Tradit Herb Drugs,2017, 48(6):1051
[16] 刘昌孝,陈士林,肖小河,等. 中药质量标志物(Q-marker):中药产品质量控制的新概念[J]. 中草药,2016, 47(9):1443 LIU CX, CHEN SL, XIAO XH, et al. A new concept on quality marker of Chinese materia medica:quality control for Chinese medicinal products[J]. Chin Tradit Herb Drugs,2016,47(9):1443
[17] 刘昌孝. 从中药资源-质量-质量标志物认识中药产业的健康发展[J]. 中草药, 2016, 47(18):3149 LIU CX. Recognizing healthy development of Chinese medicine industry from resources-quality-quality markers of Chinese medicine[J]. Chin Tradit Herb Drugs,2016, 47(18):3149

欢迎阅读《药物分析杂志》!您是该文第 251位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn

本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838